[DXCM] DexCom, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 62.51 Change: 0.41 (0.66%)
Ext. hours: Change: 0 (0%)

chart DXCM

Refresh chart

Strongest Trends Summary For DXCM

DXCM is in the long-term up 160% above S&P in 2 years and up 380% above S&P in 17 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. It offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. The company?s ambulatory product line includes SEVEN PLUS, DexCom G4 system, and DexCom G4 PLATINUM system for adults with diabetes to detect trends and track glucose patterns, to aid in the detection of hypoglycemia and hyperglycemia, and to facilitate acute and long-term therapy adjustments, as well as DexCom SHARE, a remote monitoring system, which provides secondary notification and does not replace real time continuous glucose monitoring or standard home blood glucose monitoring. Its in-hospital product line comprises GlucoClear, a blood-based in-vivo automated glucose monitoring system for use by healthcare providers in the hospital. The company also offers SweetSpot, a software platform that e

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 23.81% Sales Growth - Q/Q-13.64% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-12.04% ROE-15.34% ROI-14.97%
Current Ratio3.95 Quick Ratio3.45 Long Term Debt/Equity0.02 Debt Ratio0.25
Gross Margin67.74% Operating Margin-7.69% Net Profit Margin-8% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities4.9 M Cash From Investing Activities-25.9 M Cash From Operating Activities3.4 M Gross Profit46.5 M
Net Profit-12.9 M Operating Profit-12.7 M Total Assets189.3 M Total Current Assets146.2 M
Total Current Liabilities37 M Total Debt4.1 M Total Liabilities40.7 M Total Revenue72.8 M
Technical Data
High 52 week152.73 Low 52 week54.03 Last close140.9 Last change2.95%
RSI45.56 Average true range5.84 Beta1.28 Volume568.76 K
Simple moving average 20 days-2.91% Simple moving average 50 days4.21% Simple moving average 200 days17.41%
Performance Data
Performance Week-5.11% Performance Month-2.21% Performance Quart17.58% Performance Half2.03%
Performance Year139.54% Performance Year-to-date17.61% Volatility daily2.34% Volatility weekly5.24%
Volatility monthly10.74% Volatility yearly37.19% Relative Volume615.21% Average Volume1.47 M
New High New Low

News

2019-03-25 10:53:02 | AMN Healthcare Down on Soft Locum Tenens Business, Dull View

2019-03-25 10:49:02 | BD Remains Confident About LUTONIX DCB Despite FDA Letter

2019-03-25 06:46:00 | 3 Big Stock Charts for Monday: Twitter, UnitedHealth Group and Philip Morris

2019-03-23 09:30:01 | DexCom DXCM Down 11.8% Since Last Earnings Report: Can It Rebound?

2019-03-22 16:54:08 | HMS Holdings Gains on PI & TPM Solutions, Competition Rife

2019-03-22 15:34:07 | Here's Why You Should Retain Ecolab Stock in Your Portfolio

2019-03-22 15:19:00 | Here's Why DexCom Shares Are Dropping Today

2019-03-22 10:33:02 | DexCom, comScore, Lululemon, Nike and Under Armour highlighted as Zacks Bull and Bear of the Day

2019-03-22 06:01:10 | Bull of the Day: DexCom DXCM

2019-03-21 16:28:08 | Here's Why You Should Hold on to Cerner CERN Stock for Now

2019-03-21 15:46:25 | Spruce Point: Dexcom Could Fall 45-60%

2019-03-21 15:45:14 | Here’s What the Apple Watch Means for AAPL Stock

2019-03-20 09:30:01 | Is DexCom DXCM Outperforming Other Medical Stocks This Year?

2019-03-19 10:30:02 | Inogen's Prospects in Europe Solid Amid Trade-Related Tension

2019-03-18 09:08:01 | Veeva Systems VEEV Gains From Solid Results for Fiscal Q4

2019-03-16 12:00:00 | 3 Top Diabetes Stocks to Watch in March

2019-03-12 09:15:01 | Tech Snaps Market Out of Slump

2019-03-12 08:48:12 | Varian & Tata Trust Tie Up to Boost Radiotherapy in India

2019-03-12 07:00:11 | The Zacks Analyst Blog Highlights: Jazz Pharmaceuticals, Lululemon Athletica, ABIOMED and DexCom

2019-03-11 09:19:01 | The Best And Worst Stocks of the 10-Year Bull Market

2019-03-11 08:48:12 | HOLX vs DXCM: Which MedTech Stock is a Better Investment Pick?

2019-03-08 10:46:00 | Is DexCom a Buy?

2019-03-08 08:52:01 | Align Technology-Benco Dental Deal to Expand iTero Reach

2019-03-07 08:47:01 | GNC Holdings to Expand Portfolio With Alani Nutrition Deal

2019-03-07 08:38:01 | Tandem's Global Growth a Boost, Operating Losses a Bane

2019-03-06 08:57:01 | GNC Forms Joint Venture With IVC to Improve Cost Efficiency

2019-03-05 07:46:12 | Here's Why You Must Add Hologic HOLX to Your Portfolio Now

2019-03-05 07:42:12 | Hologic HOLX Receives Global Nods for Omni Hysteroscope

2019-03-04 08:31:01 | Here's Why You Should Snap Up Abbott ABT Stock Right Now

2019-02-28 11:49:02 | Wait for the Inevitable Pullback to Buy TNDM Stock

2019-02-28 08:19:01 | Here's Why You Should Invest in Chemed CHE Stock Right Now

2019-02-27 10:27:03 | DexCom DXCM Gets Health Canada Approval for G6 CGM System

2019-02-27 09:29:02 | Chemed Gains Ground on Solid VITAS & Roto-Rooter Businesses

2019-02-26 17:58:10 | Here's Why Investors Should Buy DexCom DXCM Stock Now

2019-02-26 07:25:00 | Market Trends Toward New Normal in Infinera, Alliant Energy, Galectin Therapeutics, DexCom, Cutera, and Care — Emerging Consolidated Expectations, Analyst Ratings

2019-02-25 16:15:00 | Dexcom Announces Upcoming Conference Presentation

2019-02-25 08:25:01 | DexCom's DXCM Q4 Earnings Beat, International Revenues Up

2019-02-25 08:20:01 | Here's Why You Should Invest in Illumina ILMN Stock Now

2019-02-22 15:43:06 | Edited Transcript of DXCM earnings conference call or presentation 21-Feb-19 9:30pm GMT

2019-02-22 13:13:00 | Dexcom G6® CGM System Receives Health Canada Approval

2019-02-22 00:56:54 | Dexcom Inc DXCM Q4 2018 Earnings Conference Call Transcript

2019-02-21 17:30:10 | DexCom DXCM Q4 Earnings and Revenues Top Estimates

2019-02-21 16:34:41 | DexCom: 4Q Earnings Snapshot

2019-02-21 16:10:00 | Dexcom Reports Fourth Quarter and Fiscal Year 2018 Financial Results

2019-02-21 07:49:12 | Masimo and Saudi Arabia MOH Collaborate for CCHD Screening

2019-02-21 07:16:12 | Luminex Hurt By Segmental Sluggishness, Stiff Competition

2019-02-15 14:00:29 | The Week Ahead In Biotech: Conferences, Clinical Trials And Earnings

2019-02-14 10:31:03 | DexCom DXCM Earnings Expected to Grow: Should You Buy?

2019-02-14 07:39:12 | Here's Why Investors Should Buy CONMED CNMD Stock Now

2019-02-13 12:38:00 | Beating the Market With Medical-Device Stocks